Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 3
This trial is looking at adding inavolisib to palbociclib and fulvestrant for breast cancer.
It is open to people whose:
cancer has stopped responding to treatment
cancer cells have a change () in a gene called PIK3CA
Recruitment start: 26 March 2021
Recruitment end: 18 August 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Turner
Roche
Last reviewed: 24 August 2023
CRUK internal database number: 17443
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
